Search hospitals > Virginia > Richmond
VCU Massey Cancer Center at Stony Point
Claim this profileRichmond, Virginia 23235
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Colorectal Cancer
183 reported clinical trials
30 medical researchers
Summary
VCU Massey Cancer Center at Stony Point is a medical facility located in Richmond, Virginia. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Colorectal Cancer and other specialties. VCU Massey Cancer Center at Stony Point is involved with conducting 183 clinical trials across 206 conditions. There are 30 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Leslie Randall, MD, and Khalid Matin.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Andrew Poklepovic, MDVirginia Commonwealth University/Massey Cancer Center5 years of reported clinical research
Expert in Cancer
Expert in Melanoma
36 reported clinical trials
85 drugs studied
Sarah W. Gordon, DOVirginia Commonwealth University/Massey Cancer Center9 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
Leslie Randall, MDVCU Massey Cancer Center at Stony Point2 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrial Cancer
19 reported clinical trials
35 drugs studied
Khalid MatinVirginia Commonwealth University/Massey Cancer Center6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
14 reported clinical trials
30 drugs studied
Clinical Trials running at VCU Massey Cancer Center at Stony Point
Prostate Cancer
Lung Cancer
Breast Cancer
Ovarian Cancer
Breast cancer
Cancer
Laryngeal Cancer
Oropharyngeal Carcinoma
Esophageal cancer
Throat Cancer
Carboplatin + Cabazitaxel
for Prostate Cancer
This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that has spread from where it first started (primary site) to other places in the body (metastatic). Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Chemotherapy drugs, such as cabazitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Prednisone is often given together with chemotherapy drugs. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs and to help the chemotherapy work. Giving carboplatin with the standard of care chemotherapy drug cabazitaxel may be better at treating metastatic castrate-resistant prostate cancer.
Recruiting2 awards Phase 35 criteria
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at VCU Massey Cancer Center at Stony Point?
VCU Massey Cancer Center at Stony Point is a medical facility located in Richmond, Virginia. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Colorectal Cancer and other specialties. VCU Massey Cancer Center at Stony Point is involved with conducting 183 clinical trials across 206 conditions. There are 30 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Leslie Randall, MD, and Khalid Matin.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.